Mulugeta Russom

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 33

Top Venues

Drugs - real world outcomes

Scientific reports

International medical case reports journal

Therapeutic advances in drug safety

National Medicines and Food Administration

European Program for Pharmacovigilance and Pharmacoepidemiology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Medicines and Food Administration Sep 01 2011

Eritrea

Head :: Eritrean Pharmacovigilance Centre

Education History

European Program for Pharmacovigilance and Pharmacoepidemiology Oct 07 2019 - Oct 30 2022

France

PHD :: Pharmacoepidemiology and Pharmacovigilance

European Program for Pharmacovigilance and Pharmacoepidemiology Sep 27 2016 - Jul 07 2017

France

MSC

Publications

Tomas Tewelde, Nuru Abdu, Dawit G Weldemariam, Natnael Bereket, Mulugeta Russom, Eyasu Habte Tesfamariam
Quality of life of dermatology outpatients and its associated factors in Halibet National Referral Hospital in Asmara, Eritrea. Scientific reports 14 (1) (2024)
Tomas Tewelde, Nuru Abdu, Dawit G Weldemariam, Natnael Bereket, Mulugeta Russom, Eyasu Habte Tesfamariam
Quality of life of dermatology outpatients and its associated factors in Halibet National Referral Hospital in Asmara, Eritrea. Scientific reports 14 (1) (2024)
Merhawi Bahta, Natnael Russom, Amon Solomon Ghebrenegus, Yohana Tecleab Okubamichael, Mulugeta Russom
Correction to: Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database. Drugs - real world outcomes (2024)
Merhawi Bahta, Natnael Russom, Amon Solomon Ghebrenegus, Yohana Tecleab Okubamichael, Mulugeta Russom
Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database. Drugs - real world outcomes (2024)
Merhawi Bahta, Natnael Russom, Amon Solomon Ghebrenegus, Yohana Tecleab Okubamichael, Mulugeta Russom
Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database. Drugs - real world outcomes (2024)
Merhawi Bahta, Natnael Russom, Amon Solomon Ghebrenegus, Yohana Tecleab Okubamichael, Mulugeta Russom
Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database. Drugs - real world outcomes (2024)
Tomas Tewelde, Nuru Abdu, Dawit G Weldemariam, Natnael Bereket, Mulugeta Russom, Eyasu Habte Tesfamariam
Quality of life of dermatology outpatients and its associated factors in Halibet National Referral Hospital in Asmara, Eritrea. Scientific reports 14 (1) (2024)
Tomas Tewelde, Nuru Abdu, Dawit G Weldemariam, Natnael Bereket, Mulugeta Russom, Eyasu Habte Tesfamariam
Quality of life of dermatology outpatients and its associated factors in Halibet National Referral Hospital in Asmara, Eritrea. Scientific reports 14 (1) (2024)
Mulugeta Russom, Daniel Y B Jeannetot, Araia Berhane Mesfin, Henok G Woldu, Bruno H Ch Stricker, Katia M C Verhamme
Liver Injury Following Isoniazid Preventive Therapy in HIV Patients Attending Halibet National Referral Hospital, Eritrea: A Prospective Cohort Study. Drugs - real world outcomes (2023)
Yodit Fitsum, Azania Werede, Abubeker Mahmud Saleh, Eyasu H Tesfamariam, Francis Magombo, Freminatos Misghina, Hermella Yemane, Iyassu Bahta, Liya Abraham, Merhawi Bahta, Merhawi Debesai, Meron Tesfagaber, Michael Ghirmai, Sirak Tesfamariam, Mulugeta Russom
Understanding, readiness, and response of healthcare professionals in combating falsified medical products in Eritrea: a population-based survey. Therapeutic advances in drug safety 14 (2023)
Sirak Tesfamariam, Merhawi Bahta, Dawit G Weldemariam, Eyasu H Tesfamariam, Hermella Yemane, Iyassu Bahta, Mulugeta Russom
Awareness, Perception, and Utilization of Skin Lightening Agents Among Females of Asmara, Eritrea: A Cross-Sectional Study. Clinical, cosmetic and investigational dermatology 16 (2023)
Yodit Fitsum, Azania Werede, Abubeker Mahmud Saleh, Eyasu H Tesfamariam, Francis Magombo, Freminatos Misghina, Hermella Yemane, Iyassu Bahta, Liya Abraham, Merhawi Bahta, Merhawi Debesai, Meron Tesfagaber, Michael Ghirmai, Sirak Tesfamariam, Mulugeta Russom
Understanding, readiness, and response of healthcare professionals in combating falsified medical products in Eritrea: a population-based survey. Therapeutic advances in drug safety 14 (2023)
Sirak Tesfamariam, Merhawi Bahta, Dawit G Weldemariam, Eyasu H Tesfamariam, Hermella Yemane, Iyassu Bahta, Mulugeta Russom
Awareness, Perception, and Utilization of Skin Lightening Agents Among Females of Asmara, Eritrea: A Cross-Sectional Study. Clinical, cosmetic and investigational dermatology 16 (2023)
Yodit Fitsum, Azania Werede, Abubeker Mahmud Saleh, Eyasu H Tesfamariam, Francis Magombo, Freminatos Misghina, Hermella Yemane, Iyassu Bahta, Liya Abraham, Merhawi Bahta, Merhawi Debesai, Meron Tesfagaber, Michael Ghirmai, Sirak Tesfamariam, Mulugeta Russom
Understanding, readiness, and response of healthcare professionals in combating falsified medical products in Eritrea: a population-based survey. Therapeutic advances in drug safety 14 (2023)
Okbu Frezgi, Mulugeta Russom
Toxic Epidermal Necrolysis Associated with Misoprostol: A Case Report. International medical case reports journal 16 (2023)
Okbu Frezgi, Mulugeta Russom
Toxic Epidermal Necrolysis Associated with Misoprostol: A Case Report. International medical case reports journal 16 (2023)
Okbu Frezgi, Mulugeta Russom
Toxic Epidermal Necrolysis Associated with Misoprostol: A Case Report. International medical case reports journal 16 (2023)
Nuru Abdu, Asmerom Mosazghi, Tedros Yehdego, Eyasu H Tesfamariam, Mulugeta Russom
Knowledge and Perceptions of Nurse Practitioners on Adverse Events Following Immunization and Barriers to Reporting in the Central Region, Eritrea: A Cross-Sectional Study. Drug, healthcare and patient safety 14 (2022)
Mulugeta Russom, Yodit Fitsum, Merhawi Debesai, Natnael Russom, Merhawi Bahta
Tamsulosin and risk of priapism: A causality assessment using Austin Bradford Hill Criteria. Pharmacology research & perspectives 10 (2) (2022)
Mulugeta Russom, Daniel Y B Jeannetot, Sirak Tesfamariam, Bruno H Ch Stricker, Katia M C Verhamme
Perspectives of Healthcare Professionals on Factors Limiting Implementation of Isoniazid Preventive Therapy in People Living with HIV in Eritrea: A Qualitative Study. Risk management and healthcare policy 15 (2022)
Mulugeta Russom, Henok G Woldu, Araia Berhane Mesfin, Daniel Y B Jeannetot, Bruno H Ch Stricker, Katia M C Verhamme
Effectiveness of a 6-Month Isoniazid on Prevention of Incident Tuberculosis Among People Living with HIV in Eritrea: A Retrospective Cohort Study. Infectious diseases and therapy 11 (1) (2022)
Merhawi Bahta, Dawit G Weldemariam, Sirak Tesfamariam, Eyasu H Tesfamariam, Mulugeta Russom
Determinants of dispensing antibiotics without prescription in Eritrea: a mixed-method qualitative study on pharmacy professionals' perspective. BMJ open 11 (8) (2021)
Mulugeta Russom, Merhawi Bahta, Merhawi Debesai, Iyassu Bahta, Abrahalei Kessete, Aziza Afendi, Yodit Fitsum, Josephine Nambozi, Solyana N Kidane, Eyasu H Tesfamariam
Knowledge, attitude and practice of antibiotics and their determinants in Eritrea: an urban population-based survey. BMJ open 11 (9) (2021)
Mulugeta Russom, Iyassu Bahta, Merhawi Debesai
Eritrean Pharmacovigilance System: Key Strategies, Success Stories, Challenges and Lessons Learned. Drug safety 44 (10) (2021)
Mulugeta Russom, Yodit Fitsum, Abiel Abraham, Ruth L Savage
Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database. Drugs - real world outcomes 8 (3) (2021)
Merhawi Bahta, Azieb Ogbaghebriel, Mulugeta Russom, Eyasu Habte Tesfamariam, Tzeggai Berhe
Impact of adverse reactions to first-generation antipsychotics on treatment adherence in outpatients with schizophrenia: a cross-sectional study. Annals of general psychiatry 20 (1) (2021)
Sirak Tesfamariam, Amon Solomon Ghebrenegus, Henok Woldu, Ephrem Fisseha, Gebremeskel Belai, Mulugeta Russom
Secondary erythrocytosis following drugs used in rifampicin/multidrug-resistant tuberculosis: a retrospective cohort study. BMJ open respiratory research 8 (1) (2021)
Lidia Habtemikael, Mulugeta Russom, Iyassu Bahta, Selam Mihreteab, Araia Berhane, Andreas Mårtensson, Jose Pedro Gil
Prevalence of CYP2C8*2 and *3 among Eritreans and its Potential Impact on Artesunate/Amodiaquine Treatment. Pharmacogenomics and personalized medicine 13 (2020)
Mulugeta Russom, Aziza Afendi, Amon Solomon Ghebrenegus
Amoxicillin and Risk of Hearing Loss: Analysis of Reported Cases Submitted to the WHO Global Database. Drug, healthcare and patient safety 12 (2020)
Nuru Abdu, Asmerom Mosazghi, Samuel Teweldemedhin, Luwam Asfaha, Makda Teshale, Mikal Kibreab, Indermeet Singh Anand, Eyasu H Tesfamariam, Mulugeta Russom
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Usage and co-prescription with other potentially interacting drugs in elderly: A cross-sectional study. PloS one 15 (10) (2020)
Merhawi Bahta, Tzeggai Berhe, Mulugeta Russom, Eyasu Habte Tesfamariam, Azieb Ogbaghebriel
Magnitude, Nature, and Risk Factors of Adverse Drug Reactions Associated with First Generation Antipsychotics in Outpatients with Schizophrenia: A Cross-Sectional Study. Integrated pharmacy research & practice 9 (2020)
Mulugeta Russom, Hager Tesfaselassie, Rozina Goitom, Tadese Ghirmai, Freweini Weldedhawariat, Abiel Berhe, Dawit Tesfai, Merhawi Debesai, Tesfit Berhane, Henok G Woldu
Risk Factors of Gout in MDR-TB Patients in Eritrea: A Case-Control Study. Tuberculosis research and treatment 2019 (2019)
Mulugeta Russom, Merhawi Debesai, Mehari Zeregabr, Araia Berhane, Theodros Tekeste, Teklezghi Teklesenbet
Serious hepatotoxicity following use of isoniazid preventive therapy in HIV patients in Eritrea. Pharmacology research & perspectives 6 (4) (2018)

Mulugeta Russom.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mulugeta Russom